Abstract

BackgroundDespite new documents published from EMA and the Italian Drug Agency with the aim of clarifying the quality assurance, efficacy and safety of biosimilar drugs, the clinicians are still reluctant...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
4CPS-158 Prescribing trends of adalimumab and etanercept biosimilar drugs in a third level hospital
O Horna Oreja ... Fj Campos Montellano
European Journal of Hospital Pharmacy | VOL. 27
O Horna Oreja, et. al.O Horna Oreja ... Fj Campos Montellano
01 Mar 2020
PUK36 DIRECT HEALTHCARE COSTS OF CHRONIC KIDNEY DISEASE MANAGEMENT IN ITALY: HOW MUCH SAVING CAN BE ACHIEVED WITH LARGER BIOSIMILAR UPTAKE?
J Sultana ... A Chinellato
Value in Health | VOL. 22
J Sultana, et. al.J Sultana ... A Chinellato
01 Nov 2019
CPC-003 A Retrospective Analysis of the Switches from Originator and Biosimilar Recombinant Human Erythropoietins in Chronic Kidney Disease
I Uomo ... M Pastorello
European Journal of Hospital Pharmacy: Science and Practice | VOL. 20
I Uomo, et. al.I Uomo ... M Pastorello
01 Mar 2013
DOP078 Are IBD specialists aware of biosimilar monoclonal antibodies? Results from a survey among ECCO members
P Michetti ... G Fiorino
Journal of Crohn's and Colitis | VOL. 8
P Michetti, et. al.P Michetti ... G Fiorino
01 Feb 2014
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers